PMID: 8601652Apr 1, 1996Paper

Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients

Journal of the American Academy of Dermatology
H S ZackheimS T Hwang

Abstract

Most patients with erythrodermic cutaneous T-cell lymphoma (CTCL) have intense, generalized, refractory pruritus. In some large series the median survival was approximately 3 years. Our purpose was to review our experience with methotrexate in the treatment of 29 patients with erythrodermic CTCL observed for up to 129 months. This is a retrospective study. Data are presented in terms of response rates, freedom from treatment failure, and overall survival. Twelve patients (41%) achieved complete remission, and five (17%) achieved partial remission for a total response rate of 58%. The median freedom from treatment failure was 31 months, and the median survival was 8.4 years. Side effects caused treatment failure in only two patients. Low-dose methotrexate is a valuable first-line treatment for the majority of patients with early to intermediate-stage erythordermic CTCL.

References

Jun 1, 1992·Journal of the American Academy of Dermatology·H S Zackheim
May 1, 1990·Journal of the American Academy of Dermatology·H S ZackheimW R Crain
Jul 1, 1988·Journal of the American Academy of Dermatology·H H RoenigkG D Weinstein
Jan 1, 1993·Journal of Cancer Research and Clinical Oncology·M Markman

❮ Previous
Next ❯

Citations

Jun 10, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C-D Klemke
May 7, 2002·Journal of Cutaneous Medicine and Surgery·Jasmin Abd-el-BakiFrancine M Foss
Apr 30, 2004·Current Treatment Options in Oncology·Jeanette Lundin, Anders Osterborg
Oct 25, 2003·Journal of the American Academy of Dermatology·Herschel S ZackheimAlex McMillan
Aug 2, 2001·Clinics in Dermatology·P GibbsP Walsh
Apr 30, 2002·American Journal of Clinical Dermatology·Narin ApisarnthanaraxMadeleine Duvic
Jun 1, 2006·American Journal of Clinical Dermatology·Margit A HuberKarin Scharffetter-Kochanek
Jun 18, 2014·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Ercole MazzeoFilippo Bertoni
Jun 7, 2014·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J P Nicolay, C-D Klemke
Jan 27, 2016·Critical Reviews in Oncology/hematology·Pier Luigi ZinzaniStefano Pileri
Nov 27, 2015·American Journal of Hematology·Ryan A Wilcox
Mar 8, 2008·Current Problems in Cancer·Benjamin D Smith, Lynn D Wilson
Mar 23, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·A Shah, A Safaya
May 21, 2014·The British Journal of Dermatology·P A WuM E Bigby
Jul 22, 2014·American Journal of Hematology·Ryan A Wilcox
Oct 13, 2011·American Journal of Hematology·Ryan A Wilcox
Apr 1, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Franz TrautingerSean Whittaker
Mar 10, 1999·Journal of the American Academy of Dermatology·W S SusserJ M Grant-Kels
Oct 5, 2015·Dermatologic Clinics·Gary S Wood, Jianqiang Wu
Jan 21, 2014·Journal of the American Academy of Dermatology·Sarah I JawedChristiane Querfeld
May 20, 2015·The Australasian Journal of Dermatology·Charlotte Fm HughesH Miles Prince
Jun 30, 2004·Leukemia & Lymphoma·D A PichardoS T Rosen
Sep 18, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Madeleine DuvicH Miles Prince
Oct 16, 2016·International Journal of Clinical Oncology·Helen Ma, Maher Abdul-Hay
Oct 10, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reed E Drews
Feb 20, 2018·The Journal of Dermatological Treatment·Thevaki WainPablo Fernandez-Peñas
Jan 29, 2020·The American Journal of Dermatopathology·Heba A AbdelkaderMona R E Abdel-Halim
Nov 26, 2002·Hematology·Joseph M ConnorsFrancine M Foss
Sep 3, 2003·European Journal of Haematology·G A KennedyH M Prince
Dec 31, 2003·The British Journal of Dermatology·S J WhittakerUNKNOWN U.K. Cutaneous Lymphoma Group
Jul 8, 2020·The Cochrane Database of Systematic Reviews·Arash ValipourTobias Weberschock
Jul 21, 1998·Seminars in Cutaneous Medicine and Surgery·K Duncan, P Heald
Jul 13, 2000·Seminars in Cutaneous Medicine and Surgery·R Russell-Jones, S Whittaker
Jul 13, 2000·Seminars in Cutaneous Medicine and Surgery·J M MucheW Sterry
Sep 28, 2001·The Annals of Pharmacotherapy·S F Wong
Jan 25, 2002·International Journal of Cancer. Journal International Du Cancer·Andreas C HäffnerFrank Oliver Nestle
Oct 4, 2011·Journal of Cutaneous Medicine and Surgery·Anil Kurian, Richard Haber
Dec 2, 2017·The Journal of Dermatological Treatment·Larisa Geskin, Daniel C Malone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.